Project Grant K08DA060977
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$193K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (CFDA 93.279 - Drug Abuse and Addiction Research Programs) provides $1,105,489 to The Leland Stanford Junior University (Stanford University) to fund research aimed at reducing the risk of persistent postoperative opioid use and opioid use disorder among older adults undergoing inpatient surgery. The key products and services to be delivered under this 2-year grant include: Augmenting an existing dataset that links...
This $779,969 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid use disorder. The key objectives are to: Prospectively capture patient-reported pain and opioid use data among individuals with opioid use disorder undergoing common surgical procedures, and develop evidence-based prescribing guidelines. Qualitatively assess the perioperative experiences...
This $701,959 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid tolerance in the United States. The key objectives are to: Prospectively capture patient-reported opioid use and pain outcomes among opioid-tolerant individuals undergoing common surgical procedures, and develop a clinical care pathway to optimize outcomes across a network of hospitals...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to assess the acceptability and feasibility of using pharmacogenomic (PGx) testing to guide opioid use disorder (OUD) treatment. The $195,728 award, effective January 1, 2025 through December 31, 2029, will support the following key activities: Identifying barriers and facilitators to the acceptability and feasibility of a PGx testing...
This $680,595 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a 5-year research project to systematically analyze over 3.1 million internal industry documents obtained through opioid litigation. The project aims to assess how prescription opioid manufacturers marketed their products as safe and non-addictive to patients, healthcare providers, and regulators, contributing to high opioid...
The National Institute on Drug Abuse (NIDA) awarded a $177,170 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMass Medical) for the "Implementation of Medications for Opioid Use Disorder in Massachusetts Jails" project. The funding will support a mixed-methods study to analyze the implementation of medications for opioid use disorder (MOUD) treatment in Massachusetts county jails. The research aims...
This $197,748 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to develop and pilot an enhanced low-dose buprenorphine initiation (LDI) program to improve treatment outcomes for individuals with opioid use disorder (OUD), especially those using fentanyl. The key objectives of this 4-year project are to: 1) identify barriers to successful LDI completion through qualitative interviews, 2)...
This K02 independent scientist award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will enhance the recipient's research career in implementation science to address the opioid overdose crisis from the emergency department (ED) setting. With $123,930 in funding from June 2024 to May 2028, the award will enable the recipient to: Evaluate implementation outcomes across partners engaged in the recipient's ongoing R01-funded...
This federal Project Grant award of $2,542,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will develop novel econometric methods and a unified framework for integrating real-world evidence (RWE) into the analysis of inconclusive randomized controlled trials (RCTs) for opioid use disorder (OUD) treatments. The project will evaluate multiple maximum likelihood estimation (MLE) approaches combined with propensity...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports an early career investigator to study disparities in the prescription of medications to treat opioid use disorder (OUD), specifically buprenorphine and methadone, and how the availability of these medications may be associated with their effectiveness against overdose. The $196,236 award, effective August 1, 2024 through July 31, 2029, will...